Dec. 23, 2022
SHANGHAI, Dec. 21, 2022 -- Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") and Porton Biologics Ltd. (“Porton biologics”) announced a strategic collaboration. Based on the one-stop solutions of both sides, this partnership will accelerate the development and commercialization of cell and gene therapy (CGT) and facilitate this sector to sca View MoreDec. 13, 2022
SHANGHAI, Dec. 29, 2022-- Wuxi Duoning Factory, one of the seven manufacturing sites owned by Duoning Biotechnology (“Duoning”), has been put into operation recently. The factory, through producing culture media and filters, is designed to provide optimal and quality-controlled bioprocess solutions as well as to meet the mass production demands View MoreDec. 21, 2022
Recently, Shanghai Duoning Biotechnology Co., Ltd. (“Duoning”) was select as a “Science and Technology Little Giant Enterprise for Cultivation”, which proves the company's independent innovation power, R&D capability and the ability for sustainable development. View MoreCopyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support:
Message-